Lord, Abbett & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-72,154
| Closed | -$8.9M | – | 639 |
|
2020
Q2 | $8.9M | Buy |
72,154
+9,763
| +16% | +$1.2M | 0.03% | 499 |
|
2020
Q1 | $5.27M | Sell |
62,391
-23,028
| -27% | -$1.95M | 0.02% | 530 |
|
2019
Q4 | $7.22M | Sell |
85,419
-36
| -0% | -$3.04K | 0.02% | 569 |
|
2019
Q3 | $5.76M | Buy |
85,455
+7
| +0% | +$472 | 0.02% | 620 |
|
2019
Q2 | $7.32M | Sell |
85,448
-23,307
| -21% | -$2M | 0.02% | 613 |
|
2019
Q1 | $9.66M | Buy |
108,755
+2,706
| +3% | +$240K | 0.03% | 566 |
|
2018
Q4 | $9.03M | Sell |
106,049
-5,599
| -5% | -$477K | 0.03% | 551 |
|
2018
Q3 | $10.8M | Buy |
111,648
+1,272
| +1% | +$123K | 0.03% | 611 |
|
2018
Q2 | $10.4M | Buy |
110,376
+47,060
| +74% | +$4.43M | 0.03% | 614 |
|
2018
Q1 | $5.13M | Buy |
+63,316
| New | +$5.13M | 0.02% | 721 |
|
2017
Q1 | – | Sell |
-64,558
| Closed | -$5.35M | – | 862 |
|
2016
Q4 | $5.35M | Sell |
64,558
-197,845
| -75% | -$16.4M | 0.02% | 727 |
|
2016
Q3 | $24.3M | Buy |
262,403
+193,749
| +282% | +$17.9M | 0.07% | 396 |
|
2016
Q2 | $5.34M | Buy |
68,654
+2,486
| +4% | +$193K | 0.02% | 697 |
|
2016
Q1 | $5.46M | Sell |
66,168
-69,923
| -51% | -$5.77M | 0.02% | 688 |
|
2015
Q4 | $14.3M | Sell |
136,091
-70,923
| -34% | -$7.43M | 0.04% | 516 |
|
2015
Q3 | $21.8M | Sell |
207,014
-177,622
| -46% | -$18.7M | 0.07% | 397 |
|
2015
Q2 | $52.6M | Buy |
384,636
+9,911
| +3% | +$1.36M | 0.14% | 229 |
|
2015
Q1 | $46.7M | Buy |
374,725
+155,714
| +71% | +$19.4M | 0.12% | 267 |
|
2014
Q4 | $19.8M | Buy |
219,011
+125,526
| +134% | +$11.3M | 0.05% | 469 |
|
2014
Q3 | $6.75M | Sell |
93,485
-118,515
| -56% | -$8.55M | 0.02% | 677 |
|
2014
Q2 | $13.2M | Sell |
212,000
-23,000
| -10% | -$1.43M | 0.03% | 589 |
|
2014
Q1 | $16M | Sell |
235,000
-78,951
| -25% | -$5.39M | 0.04% | 529 |
|
2013
Q4 | $22.1M | Buy |
313,951
+44,493
| +17% | +$3.13M | 0.05% | 511 |
|
2013
Q3 | $19.5M | Buy |
269,458
+20,748
| +8% | +$1.5M | 0.04% | 527 |
|
2013
Q2 | $13.9M | Buy |
+248,710
| New | +$13.9M | 0.03% | 570 |
|